CP and COVID-19: Duan et al. described that severe COVID-19 recipients of CP with high-titer neutralizing activity from individuals who had recovered from COVID-19 improved clinically with a rapid increase in serum neutralizing antibody titers and no detectable SARS-CoV-2 viral RNA in their blood [112].